Results 121 to 130 of about 643 (132)

Real-life monocentric Biktarvy cohort from Perugia

2022
Benedetti S, Altobelli D, De Socio G, Lanzi A, Gamboni G, Francisci D   +5 more
openaire   +1 more source

Severe rhabdomyolysis and acute asymptomatic pancreatitis following the concomitant use of Biktarvy in the setting of hyperosmolar diabetic crisis

BMJ Case Reports, 2020
Jean-Christophe Goffard, Sylvain Raoul Simeni Njonnou, Sophie Henrard   +2 more
exaly  

LACTIC ACIDOSIS ASSOCIATED WITH BIKTARVY IN A PATIENT WITH RENAL IMPAIRMENT: A CASE REPORT

CHEST
SWEEHONEY VUJJINI, SHUJA ABDUL KARIM KHAN, ZHEXIANG HE, AGBORYA TABE, MARY BURGESS   +4 more
openaire   +1 more source

Biktarvy--another INSTI-based combination for HIV.

The Medical letter on drugs and therapeutics, 2018
openaire   +1 more source

Assessment of Gastrointestinal Adverse Effects during the First Six Months of “Biktarvy” Antiretroviral Therapy: Age-Related Patterns and Their Relation with Changes of 5 kg Weight Loss/Gain in the Initial Treatment Period

Diseases (Basel, Switzerland)
Bogdan Hogea, Ahmed Abu-Awwad, Ovidiu Rosca   +2 more
exaly  

Human medicines European public assessment report (EPAR): Biktarvy, bictegravir / emtricitabine / tenofovir alafenamide, HIV Infections, Date of authorisation: 21/06/2018, Revision: 3, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Biktarvy, bictegravir / emtricitabine / tenofovir alafenamide, HIV Infections, Date of authorisation: 21/06/2018, Revision: 1, Status: Authorised

Case Medical Research, 2018
openaire   +1 more source

Safety and Effectiveness of Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide) in Patients with HIV-1 Infection: Interim Report of a Post-Marketing Surveillance Study in Korea

Infection and Chemotherapy
Shin-Woo Kim, Yeon-Sook Kim, Jeong-a Lee
exaly  

560: SEVERE LACTIC ACIDOSIS DUE TO INAPPROPRIATE BIKTARVY USE IN A PATIENT WITH HIV : Critical Care Medicine

Critical Care Medicine
Gabriel Velez Oquendo
exaly  

Testing the Safety and Efficacy of Commercial Drug Biktarvy in Subjects Known to Have the 184 Resistance Mutation to a Component in Biktarvy

Case Medical Research
exaly